65 Studies

Click the FILTER button on the right to narrow down the list of studies and find the exact types in which you are interested.

Filters Applied

Keywords: No keywords selected
Categories: No categories selected
Gender: No gender selected
Age: No age selected


Current Studies

Study Name Category Keyword Description
General Dental Screening
(Adults - Dental Studies Interest )
Details
Surveys and Registries Genetics, Tooth/Dental Age: 18 - 65 years
Gender: Both
The GO Health Center is currently recruiting participants for general screenings to be added to our clinic registry. This will allow us to screen the registry for participants eligible for all our current and future studies. Participants can be screened for multiple studies at once instead of scheduling screenings for each individual study.
TrialNet Pathway to Prevention
(Infants to Adults-Blood RelativesType 1 Diabetics)
Details
Healthy Volunteers, Procedures Diabetes, Pediatrics Age: 1 - 45 years
Gender: Both
TrialNet is a screening and early detection research program for Type 1 Diabetes. For those who participate, the autoantibodies that serve as risk indicators for the development of Type 1 will be analyzed from the blood sample. Participants will be monitored for changes in antibody positive or negative status and/or development of Type 1 Diabetes. All testing is done at no cost to families.
GDCN Registry
(Persons All Ages - Kidney Disease & Healthy )
Details
Healthy Volunteers, Surveys and Registries Behavior, Kidneys, Other, Pediatrics, Urinary Age: 0 - 99 years
Gender: Both
This is an observational study that uses clinical data and biological specimens (like blood) collected on a large group of participants with and without kidney disease. Researchers are trying to learn about the causes and markers of kidney disease.
NEPTUNE
(Persons All Ages - Nephrotic Syndrome Pre-biopsy)
Details
Surveys and Registries Kidneys Age: 0 - 80 years
Gender: Both
The purpose of this study is to learn more about three kidney diseases called nephrotic syndrome: Focal Segmental Glomerulosclerosis (FSGS), Minimal Change Disease (MCD), and Membranous Nephropathy (MN). By collecting health information and laboratory samples from individuals who have these diseases and by making this information available to researchers, we hope to gain new knowledge about these diseases and to find better treatments for them.
Cytomegalovirus in Pregnancy
(Women - Less than 23 weeks pregnant)
Details
Drug Pregnancy, Women's Health Age: 18 - 45 years
Gender: Female
CMV is a common virus that is spread like a cold or flu. We are screening pregnant women for exposure to cytomegalovirus during the early portion of their pregnancy. CMV infection during pregnancy may lead to babies being born earlier than expected, having low birth weight, smaller heads, hearing loss, and sometimes death. The purpose of our study is to see if giving CMV infected pregnant women substances that help the immune system destroy the CMV (antibodies) will result in fewer fetuses being infected with CMV.
PMS study
(Women - Menstrually-related Mood Disorder )
Details
Healthy Volunteers, Surveys and Registries Behavior, Mental Health, Nutrition, Other, Pain, Sleep, Women's Health Age: 18 - 52 years
Gender: Female
Researchers at the UNC Center for Women's Mood Disorder are conducting a research study on symptoms prior to menstruation including depression, anxiety, irritability, or mood swing severe enough to interfere with normal functioning or interpersonal relationships. This study also enrolls healthy volunteers.
RITAZAREM
(Adults - Relapsed ANCA Associated Vasculitis/AAV)
Details
Drug Kidneys, Other Age: 18 - 99 years
Gender: Both
This is a study for people who have had a relapse a of kidney disease called ANCA- associated vasculitis (AAV.) In this comparison treatment study, participants will receive 4 infusions of rituximab + prednisone. Maintenance of remission will be slowly tapered prednisone + either a rituximab infusion every 4 months for 20 months OR take azathioprine pills daily for 27 months. This study does not accept healthy volunteers.
EMBRACE
(Adults - Systemic Lupus - African American)
Details
Drug Joints, Muscles, Skin Age: 18 - 100 years
Gender: Both
This study will test treatment with monthly Benlysta infusions for African-American adults diagnosed with Systemic Lupus Erythematosus.
Hepatitis C Virus in Preganacy
(Women - Pregnant Less Than 23 Weeks - Screening)
Details
Healthy Volunteers, Medical Treatment Outcomes Pediatrics, Pregnancy, Women's Health Age: 18 - 45 years
Gender: Female
We would like to screen all pregnant women less than 23 weeks for the Hepatitis C Virus (HCV) antibody. If you test positive for the HCV antibody, we would like to follow you throughout your pregnancy and delivery, and follow your infant through 18 months of age. The purpose of this study is to gain a better understanding of the risk of transmission of HCV from mothers to their babies. Some women who test negative for the HCV antibody will be asked to be healthy controls in this study.
WISH Study
(Women - Healthy - Stress Management)
Details
Healthy Volunteers, Surveys and Registries Behavior, Mental Health, Nutrition, Other, Sleep, Women's Health Age: 18 - 55 years
Gender: Female
Researchers at the Stress and Health Research Program are conducting a research study looking at how different levels of stress can impact your life. The purpose of the research study is to compare two different programs for stress and health.
Active SLE of Joints & Skin
(Adults - Systemic Lupus Erythematosus (SLE))
Details
Drug Joints, Muscles, Other, Pain, Skin Age: 18 - 70 years
Gender: Both
This is a study for subjects diagnosed with active Systemic Lupus Erythematosus that mainly involves musculoskeletal and skin problems.
SOPPRANO
(Adults - Temporomandibular Disorders -TMD/TMJ)
Details
Drug Behavior, Mouth/Nose/Throat, Muscles, Pain, Tooth/Dental Age: 18 - 59 years
Gender: Both
Problems with the jaw muscles and the jaw itself are called temporomandibular disorders (TMD), sometimes called TMJ. The purpose of this study is to learn about a possible treatment for pain associated with TMD.
HAL-MPE1 SCIT
(Adults - Peanut Allergy )
Details
Drug Allergy, Nutrition Age: 18 - 50 years
Gender: Both
The purpose of this study is to find out if an investigational treatment for peanut allergy is safe and tolerable for people suffering from peanut allergy. The product being investigated is an injection of liquid under the skin of your arm each week for approximately 5 months. This is a Phase I study for adults who have peanut allergy.
WelKid
(Children & Adolescents -Type 2 Diabetes )
Details
Drug Diabetes, Pediatrics Age: 10 - 17 years
Gender: Both
This is a study investigating an alternative treatment for managing blood glucose and HbA1c in children & adolescents with Type 2 Diabetes. The study medication is a powder that is mixed with water, juice, or diet soda and taken with an evening meal. Study medication and supplies are provided as part of the study.
Renal Rescue
(Adults - Non-invasive Renal Cancer)
Details
Drug Cancer, Kidneys Age: 18 - 99 years
Gender: Both
This clinical trial will study if Mitogel is an effective treatment option for patients with low grade kidney cancer and may reduce the need for surgical intervention. Patients with low grade, non invasive upper kidney cancer who have not responded well to current treatments and would like to avoid removal of kidney are potential candidates for treatment with Mitogel therapy.
IntiDisc
(Adults - Normal Hearing)
Details
Healthy Volunteers, Lifestyle/Focus Group Hearing Age: 40 - 80 years
Gender: Both
The purpose of this study is to better understand why 'normal' hearing listeners complain of having difficulty hearing even with a normal audiogram. For this study, you will listen to a sequence of tones played through headphones. This study should take 2-3 one hour visits to complete.
ARTFL
(Adults - Frontotemporal Lobar Degeneration/Family)
Details
Surveys and Registries Behavior, Brain/Head, Genetics, Other Age: 18 - 85 years
Gender: Both
This study aims to build a research network and registry for persons with Frontotemporal Lobar Degeneration (FTLD or FTD) in order to aid in future clinical trials.
NAPLS-At Risk for Psychosis
(Teens-Adults - Changes in Thinking/Mood/Behavior)
Details
Healthy Volunteers, Procedures Behavior, Brain/Head, Genetics, Mental Health Age: 12 - 30 years
Gender: Both
This study is designed to better understand the cause and course of changes in thinking, feeling and behavior which may indicate someone is at risk of developing a mental illness, such as psychosis. Study procedures include clinical evaluation, MRI, EEG, blood draw and neurocognitive testing
CALIBRATE
(Adults - Lupus nephritis)
Details
Drug Kidneys, Other, Urinary Age: 18 - 99 years
Gender: Both
This is a study for persons with lupus nephritis that is comparing different treatment plans using already available drugs to learn more about what types of treatment plans work best in different people. Eligible participants will be assigned at random, like the flip of a coin, to receive either the RC (rituximab/cyclophosphamide) treatment plan or the RCB (rituximab/cyclophosphamide/belimumab) treatment plan.
XENCOR Study
(Adults - Active Systemic Lupus Erythematosus)
Details
Drug Joints, Skin Age: 18 - 65 years
Gender: Both
The XENCOR study is looking at the effectiveness of the XmAb5871 drug in improving the symptoms of persons with Systemic Lupus Erythematosus (SLE.) Treatment consists of an I.V. infusion every two weeks.
Compare-UF Women with fibroids
(Women - Scheduled for Uterine Fibroid Surgery)
Details
Medical Treatment Outcomes Pain, Stomach, Women's Health Age: 18 - 54 years
Gender: Female
The goal of the Compare-UF study is to help determine the best methods for treating uterine fibroids so that women and their health care providers can make informed decisions about treatment options. As a participant, once you enroll into the study, you will be asked to complete a questionnaire once every year up to 4 years. You will also be asked to provide a blood sample, but this is optional. Your doctor can refer you to this study, or you can refer yourself.
The BIOGEN Study
(Adults - Systemic/Cutaneous Lupus Erythematosus )
Details
Drug Joints, Skin Age: 18 - 75 years
Gender: Both
The BIOGEN study is researching the effectiveness of the B11B059 drug to treat skin and joint manifestations of Systemic/ or Cutaneous Lupus Erythematosus (SLE and CLE.) This study involves getting a subcutaneous (under the skin) application of the study drug or a placebo (inactive substance) on a monthly basis.
Gammoz
(Adults - Mild Allergic Asthmatics )
Details
Medical Treatment Outcomes Allergy, Asthma Age: 18 - 45 years
Gender: Both
The purpose of this study is to look at the effects of 1200mg gamma tocopherol (yT) vitamin given daily on the response of the airway in mild asthmatics after exposure to ozone (O3)
The RESOLVE Study
(Adults - SLE with cutaneous activity)
Details
Drug Skin Age: 18 - 70 years
Gender: Both
The RESOLVE study is looking at the effectiveness of the RSLV-132 drug in treating cutaneous (skin) manifestations of Systemic Lupus Erythematosus (SLE.) This study involves IV infusions of the study drug or placebo every two weeks.
BI 655064 Anti-CD40
(Adults - Lupus Nephritis)
Details
Drug Kidneys, Other Age: 18 - 70 years
Gender: Both
The purpose of this research study is to test the safety, the effects of 3 doses of an investigational drug, BI655064, and how well this study drug is tolerated in people with LN (lupus of the kidney) compared to placebo as add-on therapy to standard of care treatments (the usual treatment for a disease).
Dental Composite/Restorations
(Adults - Dental Cavities)
Details
Device Mouth/Nose/Throat, Pain, Tooth/Dental Age: 18 - 99 years
Gender: Both
We are conducting a research study that evaluates the wear, durability and function of an aftermarket tooth colored filling material specifically designed for the back teeth. This tooth colored filling material will be compared to the industry standard material used on adult permanent teeth. You will receive 2 fillings.
CogNiT
(Adolescents -Sibling/Parent Schizophrenia/Bipolar)
Details
Healthy Volunteers, Procedures Brain/Head, Mental Health, Pediatrics Age: 9 - 16 years
Gender: Both
This research study is designed to examine how the brain responds to stress in adolescents using state of the art methods for clinical assessments and brain imaging. Participants in this study need to have a brother, sister or parent with schizophrenia or bipolar disorder.
Free Flowing
(Adults - Bladder Cancer)
Details
Drug Cancer, Urinary Age: 18 - 99 years
Gender: Both
This study is evaluating a product to find out if it is a viable treatment for patients with non-muscle invasive bladder cancer that have failed BCG treatment. If it is effective, it might offer treatment to help avoid more invasive therapies or drugs with known increased risks of side effects. This study is for patients with High Grade Non Muscle Invasive Bladder Cancer who have failed treatment with BCG or had recurrence of bladder cancer after BCG treatment.
DRCR W
(Adults - Severe NPDR Eye Disease)
Details
Drug Diabetes, Eyes Age: 18 - 99 years
Gender: Both
To participate in this study, you must have a diagnois of severe non-proliferative diabetic retinopathy (NPDR) . You will receive either the study drug by injection or a nonactive drug by injection, determined at random (like the flip of a coin.)
TULIP Study
(Adults - Lupus Nephritis)
Details
Drug Kidneys, Other Age: 18 - 70 years
Gender: Both
The purpose of this study is to see if an investigational drug called anifrolumab may have an effect in treating lupus nephritis, to see how well it is tolerated, and to measure levels of anifrolumab in the blood.
Peanut vaccine trial
(Adults - Peanut Allergy )
Details
Drug Allergy, Nutrition Age: 18 - 55 years
Gender: Both
This study is testing the safety of a novel vaccine which may increase tolerance to peanuts in adults who are allergic to peanut.
Naltrexone and Attention Study
(Men - Right-Handed Alcohol Drinkers)
Details
Drug Alcohol Abuse, Behavior, Brain/Head, Drug/Substance Abuse, Men's Health Age: 22 - 40 years
Gender: Male
We are conducting a neuroimaging study to examine the brain mechanisms of attention to alcohol cues. The study will test the effect of a medication used to treat alcohol dependence, naltrexone, on responses to alcohol and reward cues and on the connections between brain areas.
RADIANCE-HTN
(Adults - Hypertension)
Details
Device Heart/Cardiovascular, High Blood Pressure Age: 18 - 75 years
Gender: Both
This research study is evaluating the ability of the Paradise® Renal Denervation System to lower blood pressure in patient that have high blood pressure.
EDS
(Infants/Toddlers - Healthy and At-risk for Autism)
Details
Device Brain/Head, Other, Pediatrics, Sleep Age: 1 - 2 years
Gender: Both
To better understand how infant sleep develops and compares to other populations, researchers at UNC are examining developmental growth and investigating infant sleep using a high-density electroencephalogram (hdEEG) recorder.
T2DM and the risk for CKD
(Adults - Type 2 Diabetes)
Details
Surveys and Registries Diabetes, Kidneys, Urinary Age: 18 - 75 years
Gender: Both
Kidney researchers want to learn more about the progression of kidney disease due to diabetes. This is a registry - participants in this study will have their medical records reviewed and will donate blood and urine samples that will be studied by the researchers. Participants can choose to give a blood and urine sample either one time or every few years.
TRIUMPH
(Adults - MSM/TGW - HIV-uninfected )
Details
Drug Men's Health, Women's Health Age: 18 - 99 years
Gender: Both
UNC is conducting a research study that is looking to compare oral Truvada as PrEP with a long-acting injectable medication Cabotegravir in HIV-uninfected men and transgender women who have sex with men. This will require taking oral medication daily and receiving periodic injections. The study requires several visits.
Adult Pemphigus Clinical Trial
(Adults - Active Skin Disease-Pemphigus)
Details
Drug Skin Age: 18 - 99 years
Gender: Both
This is a study looking at the effect a new investigational infusion medication for patients with chronic pemphigus (vulgaris or foliaceus).
ADVOCATE Study
(Adults - ANCA Vasculitis - New or Relapsing)
Details
Drug Hearing, Kidneys, Mouth/Nose/Throat Age: 18 - 99 years
Gender: Both
The purpose of this study is to see if a new oral medication (avacopan) when given along with standard of care medicines (cyclphosphamide or rituximab) is effective in replacing oral steroids (prednsone) and induce and sustain disease remission.
CI Children - Unilateral
(Children - Deafness - One Ear)
Details
Device Ears, Hearing, Pediatrics Age: - years
Gender: Both
The primary goal of this study is to determine whether children with unilateral hearing loss experience an improvement in speech understanding, hearing in noise, localization, and quality of life with a cochlear implant as compared to an unaided listening condition.
Baby Connectome Project
(Newborns-Children - Typically Developing - Brain )
Details
Healthy Volunteers, Procedures Behavior, Brain/Head, Pediatrics Age: 0 - 5 years
Gender: Both
The goal of this study is to further learn how a healthy human brain changes and works, specifically at a very young age. This study will help us learn more about children’s mental, emotional and behavioral development, as well as understanding the possible causes of learning disabilities and neurodevelopmental disorders. This will be done by magnetic resonance imaging (MRI) scans of the child’s brain during various times of development. Not only is MRI a safe and non-invasive procedure, but there will be no medication or sedation used for this study at any point.
PRIORITY
(Men - Being Monitored for Prostate Cancer)
Details
Device Men's Health Age: 45 - 85 years
Gender: Male
Patients with previous negative prostate biopsy, but still considered at risk for prostate cancer may be eligible to take part in a study where they will have have further tests performed along with their scheduled repeat prostate biopsy. These research performed tests are being evaluated in hopes of making more accurate diagnosis and reduce the need repeat biopsies.
What's the Gist?
(Adults - Rheumatoid Arthritis (RA) )
Details
Surveys and Registries Arthritis, Behavior, Bones, Hands/Feet, Joints, Other, Pain Age: 18 - 99 years
Gender: Both
This study will compare different types of written materials designed to educate patients with rheumatoid arthritis about the risks and benefits of different medications used to treat rheumatoid arthritis. In addition, researchers will learn more about how well an educational program aimed at helping helping patients understand complex information enhances their knowledge of treatment options and their ability to make informed decisions about treatment options.
Herbal Supplementation
(Men - Low Testosterone)
Details
Medical Treatment Outcomes Men's Health Age: 30 - 99 years
Gender: Male
This study is examining the effects of an herbal supplement on sexual health, function, and quality of life in men.
AURORA Study
(Adults - Lupus Nephritis)
Details
Drug Kidneys, Other Age: 18 - 75 years
Gender: Both
This study is to test how well a new oral medicine (Orelvo) works in treating active lupus nephritis, which is an inflammation of the kidney caused by lupus.
Epidermolysis Bullosa Simplex
(Children/Adults Epidermolysis Bullosa Simplex-EBS)
Details
Drug Pediatrics, Skin Age: 4 - 99 years
Gender: Both
This is a clinical trial for children to adults from ages 4 and up comparing diacerin ointment to placebo for the treatment of a skin condition called Epidermolysis Bullosa Simplex ( EBS) causing lesions on the body.
Changes Study
(Women - Menopause Transition)
Details
Drug, Healthy Volunteers Behavior, Mental Health, Other, Women's Health Age: 45 - 60 years
Gender: Female
We are interested in estrogen's effects on mood and stress during the menopause transition. Participant visits are weekly, and most can be done either at home or our lab. Participants will wear either an estrogen patch or a placebo (inactive product) patch. This study accepts generally healthy volunteers.
Vitamin D Study
(Adults - Smokers - Vitamin D Effects)
Details
Medical Treatment Outcomes Breathing, Lungs, Other, Smoking Age: 18 - 80 years
Gender: Both
Researchers are testing the effects of vitamin D on blood and lung samples of regular smokers.
COPD Registry
(Adults - Current or Former Smokers)
Details
Surveys and Registries Behavior, Breathing, Lungs, Other, Smoking Age: 40 - 99 years
Gender: Both
Researchers are looking for current and former smokers with or without COPD to enroll in a registry to be contacted for future studies.
NIAAA Study of Binge Drinking
(Adults - Alcohol Use)
Details
Drug, Healthy Volunteers Alcohol Abuse Age: 18 - 44 years
Gender: Both
The University of North Carolina at Chapel Hill is seeking volunteers for a research study testing the efficacy of the FDA approved medication bupropion in reducing binge drinking episodes. Bupropion is currently used to treat depression, but recently, studies have suggested that bupropion might be helpful in the treatment of binge drinking. The study will be “blinded” which means that neither you nor the study staff will know if you are taking bupropion or placebo. Participants will take the study medication for 3 months and attend 10 visits.
PPD ACT
(Women - Ever Experienced Post Partum Depression )
Details
Surveys and Registries Mental Health, Pregnancy, Women's Health Age: 18 - 99 years
Gender: Female
PPD ACT is a research app for women who have ever experienced postpartum depression (PPD) or psychosis (PPP.) The goal of the study is to improve detection, treatment and prevention of PPD and PPP by finding the genetic basis of these disorders. Women who participate will download the PPD ACT app, fill out questionnaires and if eligible, submit a saliva sample. Study 2: Additionally, if you have given birth in the last 3 months and are currently experiencing symptoms of PPD, you may also qualify for participation in a 6-week study based at UNC Chapel Hill clinics where you will wear an Apple Watch to track your mood and symptoms to help us learn how to develop better treatments for PPD. Participation in this study requires an iPhone 5 or above and willingness to be seen at the UNC Chapel Hill Out-Patient Psychiatry Clinic.
DLB Consortium
(Adults - Dementia with Lewy Bodies or likely DLB)
Details
Surveys and Registries Brain/Head, Mental Health Age: 40 - 90 years
Gender: Both
This study aims to establish a research network and registry for persons with Dementia with Lewy Bodies (DLB) in order to characterize the disease and aid in future clinical trials.
CONTENT
(Adults- MS or Spinal Cord Injury Incontinence)
Details
Drug Brain/Head, Men's Health, Urinary, Women's Health Age: 18 - 80 years
Gender: Both
Many people experiencing urine leakage are not satisfied with their current treatments. The CONTENT clinical research trial is currently evaluating an investigational drug for its effectiveness on urine leakage in patients with Multiple Sclerosis (MS) or who have a spinal cord injury.
BCG Strain Comparison
(Males and Females 18 and over with Bladder Cancer)
Details
Drug Cancer Age: 18 - 99 years
Gender: Both
This study will evaluate differences and effectiveness of two treatments on bladder cancer. Patients with newly diagnosed High Grade Non Muscle Invasive Bladder cancer who meet qualifications will be treated with standard BCG treatment or with Tokyo-172 BCG.
Pulp Regeneration Study
(Children-Teens-Adults - Endodontic Treatments)
Details
Medical Treatment Outcomes Pediatrics, Tooth/Dental Age: 6 - 20 years
Gender: Both
Study comparing the outcomes of two different endodontic treatments that can be done for infected immature teeth with disease involving necrotic pulp.
Low Motivation and Pleasure
(Adults- Therapy for Low Motivation & Pleasure)
Details
Procedures Behavior, Mental Health, Other Age: 18 - 50 years
Gender: Both
Researchers at UNC and Duke are evaluating a new talk therapy. They are looking for adults who are not currently taking any psychiatric medications and/or not currently in psychotherapy and are experiencing symptoms of low motivation and pleasure to participate in this study. Eligible participants will receive up to 15 therapy sessions from a Duke clinician at no cost in addition to other compensation.
Moderate to Severe AD Study
(Adults- Atopic Dermatitis / Eczema )
Details
Drug Skin Age: 18 - 99 years
Gender: Both
This is a study of investigational medication for the treatment of moderate to severe atopic dermatitis or eczema in adults ages 18 and older .
PALIS
(Adults - Osteoarthritis & Their Partners)
Details
Lifestyle/Focus Group Arthritis, Behavior, Joints, Other, Pain Age: 40 - 99 years
Gender: Both
This study is for people with osteoarthritis or with pain and stiffness in their hip or knee joints. We are looking at how people with osteoarthritis work together with their partner to overcome barriers to physical activity.
Milkshake Study
(Adults - Generally Healthy )
Details
Drug Brain/Head, Diabetes, Nutrition, Obesity Age: 18 - 35 years
Gender: Both
This is a neuroimaging study looking at the brain's response to a milkshake and a drug for Type 2 diabetes. The goal is to see how a Type 2 diabetes drug affects how hungry a person feels. This study accepts healthy volunteers only.
Creating a Drowsiness Database
(Adults - Sleep and Driving)
Details
Healthy Volunteers, Surveys and Registries Behavior, Sleep Age: 18 - 99 years
Gender: Both
We will be collecting video of subjects performing simple tasks and information about their sleep habits. This will be used to test computer vision techniques on measuring drowsiness. Participants must have driving experience.
Children Hearing Study
(Children-Normal Hearing-Bilingual or Monolingual)
Details
Healthy Volunteers, Procedures Behavior, Hearing, Pediatrics Age: 4 - 17 years
Gender: Both
The purpose of the research is to develop a pediatric test of speech perception that can be administered in both English and Spanish. During the study, the participant will sit in a soundproof room and listen to words presented over headphones or loudspeakers. The participant will also complete tests of language proficiency, receptive vocabulary and nonverbal intelligence. This study should take 1-2 visits of 1-2.5 hours each. We are enrolling persons ages 4-17 that are bilingual English-Spanish speakers and also monolingual (English-only or Spanish only) speakers.
BPS
(Adults - Chronic Low Back Pain )
Details
Device Pain Age: 18 - 65 years
Gender: Both
This study is evaluating the effect of non-invasive brain stimulation on chronic low back pain.
FIT-D
(Adults- Experiencing fecal incontinence)
Details
Healthy Volunteers, Surveys and Registries Digestion, Men's Health, Other, Stomach, Women's Health Age: 18 - 99 years
Gender: Both
This is a diary research study where participants are asked to complete a 28 day bowel symptom diary, come in for 2 in-person visits, and participate in 2 telephone calls. Researchers are working to learn more about symptoms of fecal incontinence; no treatment or intervention is involved in this research study.
Everyday behavior and health
(People in a romantic relationship)
Details
Surveys and Registries Behavior, Men's Health, Mental Health, Women's Health Age: 18 - 59 years
Gender: Both
We are interested in everyday social behavior in health. Because we are interested in how your social interactions play a role in your physical health, we will be taking blood samples through a simple prick of your finger (like diabetics do on a daily basis). Throughout the four weeks, you will also complete four brief online questionnaires.
I-CAT/ Mindfulness
(Teens & Adults - Schizophrenia Spectrum Disorders)
Details
Lifestyle/Focus Group Behavior, Drug/Substance Abuse, Mental Health, Other, Pediatrics Age: 15 - 35 years
Gender: Both
The I-CAT Study is a therapy study for people with First Episode Psychosis aimed at improving stress reactions. The study involves assessment visits with a researcher and free weekly or bi-weekly therapy sessions with a trained clinician.
E-Cigarettes
(18-40 year old adults in good general health)
Details
Healthy Volunteers, Lifestyle/Focus Group Behavior, Lungs, Mouth/Nose/Throat, Smoking, Tooth/Dental Age: 18 - 40 years
Gender: Both
This study looks at the effects of e-cigarettes on the oral cavity (mouth area) in comparison to smokers and non-smokers.